How Much Time Should Be Waited and What Are the Main Findings to Evaluate the Hepatocellular Carcinoma Response to Regorafenib? A Real-Life Experience

<div>Computed tomography performed on April 8, 2019, showing a clear reduction of the liver tumor in the arterial phase, underscored by the red line. Instead of arterial phase enhancement, the tumor was now fulfilled by necrotic tissue.</div>

Canadian Journal of Gastroenterology and Hepatology

fig4

Figure 4

Figure 4: How Much Time Should Be Waited and What Are the Main Findings to Evaluate the Hepatocellular Carcinoma Response to Regorafenib? A Real-Life Experience 

Figure 4 | How Much Time Should Be Waited and What Are the Main Findings to Evaluate the Hepatocellular Carcinoma Response to Regorafenib? A Real-Life Experience 